|
Sotac Pharmaceuticals Ltd
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
143.48 Cr.
|
P/BV
|
3.04
|
Book Value (Rs.)
|
42.67
|
|
52 Week High/Low (Rs.)
|
203/88
|
FV/ML
|
10/1200
|
P/E(X)
|
17.88
|
|
Bookclosure
|
|
EPS (Rs.)
|
7.26
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 96.99 | 103.83 | 77.48 | 73.15 | 48.84 |
| Total Operating Revenues | 96.99 | 103.83 | 77.48 | 73.15 | 48.84 |
| | | | | | |
| Other Income | 3.90 | 0.49 | 0.35 | 0.22 | 0.11 |
| Total Revenue | 100.88 | 104.32 | 77.83 | 73.37 | 48.95 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 62.93 | 77.76 | 61.15 | 56.16 | 39.67 |
| Purchase Of Stock-In Trade | 1.33 | 2.62 | 0.53 | 0.27 | 0.23 |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 3.84 | 2.39 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 4.05 | -0.76 | -4.41 | -0.45 | -0.51 |
| Employee Benefit Expenses | 3.17 | 4.00 | 4.23 | 2.98 | 2.82 |
| Finance Costs | 2.58 | 1.70 | 1.98 | 0.53 | 1.02 |
| Depreciation And Amortisation Expenses | 3.84 | 3.10 | 2.28 | 1.13 | 2.59 |
| Other Expenses | 11.86 | 11.71 | 8.74 | 4.22 | 2.79 |
| Total Expenses | 89.76 | 100.12 | 74.49 | 68.68 | 51.01 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 11.12 | 4.20 | 3.35 | 4.69 | -2.06 |
| | | | | | |
| Exceptional Items | 0.00 | -0.23 | 0.58 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 11.12 | 3.96 | 3.93 | 4.69 | -2.06 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 1.84 | 2.13 | 1.68 | 1.86 | 0.42 |
| Deferred Tax | 0.00 | -1.70 | -0.04 | -0.04 | -0.11 |
| Tax For Earlier Years | 0.00 | -0.04 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | 1.84 | 0.38 | 1.64 | 1.82 | 0.31 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 9.28 | 3.58 | 2.29 | 2.88 | -2.37 |
| | | | | | |
| Profit/Loss From Continuing Operations | 9.28 | 3.58 | 2.29 | 2.88 | -2.37 |
| | | | | | |
| Profit/Loss For The Period | 9.28 | 3.58 | 2.29 | 2.88 | -2.37 |
| | | | | | |
| Minority Interest | -1.25 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 8.03 | 3.58 | 2.29 | 2.88 | -2.37 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 7.26 | 3.90 | 2.84 | 12.51 | -10.28 |
| Diluted EPS (Rs.) | 7.26 | 3.90 | 2.84 | 12.51 | -10.28 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.46 | 0.00 |
